Pursuant to Regulation 30, read with Part A of schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Akums Drugs and Pharmaceuticals has informed that Ashish Sharma, VicePresident- ESG & Sustainability, designated as Senior Management Personnel of the Company, has resigned from his position to explore new professional opportunities. It is further informed that there are no other material reasons for the resignation other than the reasons mentioned above. The Company has accepted his resignation and has relieved him from the duties w.e.f 25th March, 2025. Details required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with the SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 are provided herein as Annexure-A.
The above information is a part of company’s filings submitted to BSE.
